TPB
Turning Point Brands, Inc.Price & Indicators
Blended from price, positioning & fundamentals · daily-close · not investment advice.
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted Diluted EPS non-GAAP | $0.76 | Q1 2026 | — |
| Modern Oral Net Sales | $41.3M | Q4 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Tobacco — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TPB
this stock
Turning Point Brands, Inc.
|
$1.66B | -20.6% | — | 27.6 | 9.5% |
|
PM
Philip Morris International Inc.
|
$284.08B | +14.6% | +10.7% | 25.7 | 1.1% |
|
BTI
British American Tobacco p.l.c.
|
$125.18B | +10.7% | — | — | 0.3% |
|
MO
Altria Group, Inc.
|
$121.56B | +28.2% | -3.1% | 15.2 | 3.1% |
|
RLX
RLX Technology Inc.
|
$2.36B | -17.2% | +50.3% | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TPB | +2.4% | -0.4% | -16.4% | +1.3% | -20.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +1.0% | +0.9% | -24.4% | +1.6% | -29.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.